Alexion Pharmaceuticals to Initiate Phase 3 Study for Ultomiris as a Potential Coronavirus Treatment [The Motley Fool]
Alexion Pharmaceuticals, Inc (ALXN)
Last alexion pharmaceuticals, inc earnings: 1/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.alexion.com/investor-relations
Company Research
Source: The Motley Fool
Alexion Pharmaceuticals(NASDAQ:ALXNThis study, which is set to start in May, will enroll about 70 patients in several countries that have been severely impacted by the ongoing outbreak. It will focus on patients with severe manifestations of COVID-9, namely "those who are hospitalized with severe pneumonia or acute respiratory distress syndrome."Image Source: Getty Images.Several otherpharma companiesGilead SciencesNASDAQ:GILDWhile we don't have data from these clinical trials yet, early anecdotal results from the arm of a remdesivir study being conducted at University of Chicago Medicine wereencouragingHowever, even the doctor heading the overseeing the remdesivir study at University of Chicago Hospital warned that it was too early to draw definitive conclusions, and because the study does not include a control/placebo arm, interpreting the results will be more difficult.
Show less
Read more
Impact Snapshot
Event Time:
ALXN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALXN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALXN alerts
High impacting Alexion Pharmaceuticals, Inc news events
Weekly update
A roundup of the hottest topics